Erratum to: The COMET Open-label Phase II Study of Neoadjuvant FOLFOX or XELOX Treatment Combined with Molecular Targeting Monoclonal Antibodies in Patients with Resectable Liver Metastasis of Colorectal Cancer.

Ann Surg Oncol

Department of Surgery, Nagoya National Hospital, Nagoya, Japan.

Published: December 2016

Download full-text PDF	Source
http://dx.doi.org/10.1245/s10434-016-5593-5	DOI Listing

Publication Analysis

erratum comet

comet open-label

open-label phase

phase study

study neoadjuvant

neoadjuvant folfox

folfox xelox

xelox treatment

treatment combined

combined molecular

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!